Prespecified secondary analysis of SMART-CHOICE 3: in 2,089 patients with diabetes after PCI and standard DAPT, clopidogrel vs aspirin monotherapy lowered death, MI or stroke (4.5% vs 9.1%; HR 0.57) with similar bleeding (2.9% vs 2.9%); no significant diabetes interaction.
Secondary analysisn = 2,089
Lee et al. Clopidogrel vs Aspirin According to Diabetes Mellitus: A Prespecified Analysis of the SMART-CHOICE 3 Trial